|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 9/00 | (2006.01) |
| A61K 31/56 | (2013.01) | ||
| A61K 9/48 | (2006.01) | ||
| A61K 31/196 | (2013.01) | ||
| A61K 31/58 | (2013.01) | ||
| A61K 9/70 | (2006.01) | ||
| A61K 9/006 | (2013.01) | ||
| A61K 31/196 | (2006.01) | ||
| A61K 9/0031 | (2013.01) | ||
| A61K 31/56 | (2006.01) | ||
| A61K 31/58 | (2006.01) | ||
| A61K 9/0034 | (2013.01) | ||
| A61J 3/07 | (2006.01) | ||
| A61K 9/7007 | (2013.01) | ||
| A61K 47/10 | (2017.01) | ||
| A61K 9/4866 | (2013.01) | ||
| A61K 47/32 | (2006.01) | ||
| A61K 47/36 | (2013.01) | ||
| A61K 47/36 | (2006.01) | ||
| A61K 47/38 | (2013.01) | ||
| A61K 47/38 | (2006.01) | ||
| A61K 47/32 | (2013.01) | ||
| A61M 31/00 | (2006.01) | ||
| A61K 47/10 | (2013.01) | ||
| A61J 3/074 | (2013.01) | ||
| A61J 7/0061 | (2013.01) | ||
| A61M 31/002 | (2013.01) | ||
| A61M2210/1475 | (2013.01) | ||
| A61M2210/1067 | (2013.01) |
| (11) | Number of the document | 3937902 |
| (13) | Kind of document | T |
| (96) | European patent application number | 20713215.0 |
| Date of filing the European patent application | 2020-03-13 | |
| (97) | Date of publication of the European application | 2022-01-19 |
| (45) | Date of publication and mention of the grant of the patent | 2023-11-01 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2020/056934 |
| Date | 2020-03-13 |
| (87) | Number | WO 2020/183005 |
| Date | 2020-09-17 |
| (30) | Number | Date | Country code |
| 19162908 | 2019-03-14 | EP | |
| 19192961 | 2019-08-21 | EP |
| (72) |
KRAUSE, Julius , DE
|
| (73) |
EsoCap AG ,
Malzgasse 9, 4052 Basel,
CH
|
| (54) | PHARMACEUTICAL DOSAGE FORM FOR APPLICATION TO MUCOUS MEMBRANES AND METHODS FOR PRODUCING SAME |
| PHARMACEUTICAL DOSAGE FORM FOR APPLICATION TO MUCOUS MEMBRANES AND METHODS FOR PRODUCING SAME |